BLISSGVS Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > blissgvs

Technical Analysis

Technical Strength: 4.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 49.6. According to RSI analysis, blissgvs is marginally weak. 4.0 BLISSGVS RSI Chart
MACD (?) MACD: -0.0964 and Signal Line: 1.12. According to MACD analysis, blissgvs is technically weak. 2.0 BLISSGVS MACD Chart
Simple Moving Average (?) Price just got above it's 50-day simple moving average which is a positive signal. According to simple moving average analysis, blissgvs is facing resistance from it's 20-day simple moving average at 206.635 and support level is at 201. 8.0 BLISSGVS Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, blissgvs is facing resistance from it's 20-day exponential moving average at 203.8012 and support level is at 199. 3.0 BLISSGVS Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.303. 5.0 BLISSGVS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 195.038 and 187.25. Resistance level is 220.25. 6.5 BLISSGVS Fibonacci Retracement Chart
Average True Range (?) ATR: 6.66 NA BLISSGVS Average True Range Chart
Average Directional Index (?) ADX is 22.6 which means BLISSGVS is in a trading range and there is no trend. NA BLISSGVS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 23, 2018
Open Price 199.05
High Price 205.5
Low Price 198.3
Close Price 203.05
Absolute Change 3.15
Percentage Change 1.58%
Weekly Change 1.15%
Monthly Change -5.65%
Yearly Change 33.5%
52-week high 220.25
52-week low 129.15
Corporate Actions
ExDate Purpose
September 18, 2017 AGM/DIV-RE 0.60 PER SHARE
September 06, 2016 AGM/DIV RE 0.50 PER SHARE
September 08, 2015 AGM/DIV-RE 0.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.763
Confidence in Beta6.38%
Market Capital Rs. 2094.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 6.35
TTM Price-to-Earnings (P/E) Ratio 32
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 January 2018: Deliverable Quantity:2.27e+05 NA BLISSGVS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 January 2018: Daily Volatility:0.2675 NA BLISSGVS Annualized Daily Volatility (Spot Price) Chart


January 22, 2018 BlOutcome of Board Meetingliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on January 19, 2018.
January 22, 2018 BlUpdatesliss GVS Pharma Limited has informed the Exchange regarding 'Earning Presentation 9M/Q3-FY18'.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 15, 2018 January 19, 2018 ToResultso consider inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2017.
January 05, 2018 January 11, 2018 foOthersor considering disinvestment of subsidiary business.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 191.9 Rs. 195.1 Rs. 199.1 Rs. 202.3 Rs. 206.3 Rs. 209.5 Rs. 213.5